Taj Distributors

Cancer treatment is constantly evolving, with new targeted therapies improving patient outcomes. Capivast 200 mg (Capivasertib) Rx is a revolutionary oncology medication designed to inhibit cancer cell growth by blocking the AKT pathway. Manufactured by Everest Pharmaceuticals Ltd. and supplied by Orio Pharma, this advanced treatment provides hope to patients battling breast, prostate, and other cancers. Orio Pharma is dedicated to ensuring global access to high-quality oncology medications, making cancer care more effective and affordable.                                                                                                                                                                                                                                                            Capivast contains Capivasertib, an AKT inhibitor that plays a crucial role in stopping cancer cell proliferation. Many cancers rely on the AKT signaling pathway for survival and growth. By specifically targeting and inhibiting this pathway, Capivast 200 mg helps slow disease progression, making it a promising treatment for various cancer types, including hormone receptor-positive breast cancer.